Central lab case study

Pharma clinical study in patients treated for cancer
See all the case studiesGet in touch

Key information

Objective

Analysis of safety parameters and biomarkers of intestinal microbiota

Study design

– Multinational multicentric: France, Germany, Italy and Poland

– Phase II interventional study

– 24 patients included

Our mission

Kitting

Sample analysis

Logistics

main challenges

– Kit supply and provision of -80°C equipement for the investigational centres

– Coordination by a different CRO

– Adjustement of the sampling kit design to a specific population of patients

– Management and logistics of immediate shipment of samples after collection from recruiting centres to Biofortis (24-48 hours from sampling to sample reception)